My research is about a vaccine... Respiratory syncytial virus is the leading respiratory cause of hospitalization in infants and young children in the United States and in the world. There is still no vaccine licensed against this pathogen.
The major obstacle to vaccine development has been the enhanced respiratory disease that affected children immunized with a formalin inactivated vaccine against this virus in the sixties.
The mechanism of illness of Enhanced Respiratory Disease has not been completely elucidated.
I work to understand what cause severity in those children and to develop a safe vaccine.
Young Ambassador to Argentina, Patricio Acosta